Colorectal Cancer Awareness, Research, Education and Screening (CARES)

Federally qualified health centers (FQHCs) and other community health clinics (CHCs) provide
comprehensive primary health care for underserved patients. Recently, high-sensitivity and
high-specificity fecal occult blood tests (FOBT) and fecal immunochemical tests (FIT) have
emerged as a preferred initial screening modality within clinics due to convenience, ease of
use, and low cost compared with colonoscopy. FOBT/FIT may help to reduce colorectal cancer
screening (CRC) screening disparities and overcome several previously mentioned factors that
often account for suboptimal CRC screening rates.

Inclusion Criteria:

- Racially-ethnically diverse adult men and women

- Average risk individuals who have no personal diagnosis, or presumptive symptoms of
colorectal cancer (CRC), or are not at high risk

- Self-report as not current on screening

- Provide at least two forms of contact information and contact information of a
relative (not living with respondent) to facilitate follow-up contacts

- Are able to speak, read and write English because the instruments and CARES
intervention are available only in English at this time. We recognize that
interventions are needed for non-English speaking populations, therefore, once we find
promise in the English language CARES intervention materials, we will move forward
with conducting other studies that involve translation of measures and cultural
adaptation of the CARES intervention materials into Spanish or Haitian Creole.

Exclusion Criteria:

- Individuals who have participated in a CRCS research study in the past 1 year will not
be eligible for this study.

- Recent screening criteria relates to not having had I-FOBT within the previous year,
flex sig within the previous 5 years, a double-contrast barium enema (DCBE) x-ray with
the previous 5 years, or a colonoscopy within the previous 10 years.

- Within the recruitment and intervention frame, high risk individuals (due to strong
family history, ulcerative colitis, polyposis syndromes) are excluded because they may
be eligible for CRC screening before age 50, and the preferred screening option is
certainly colonoscopy which is beyond the primary focus of the current study.